Abstract
BackgroundSince the discovery of the sphingosine-1-phosphate (S1P) pathway and its potentially beneficial role of inducing lymphocyte retention and subsequent immunomodulation [1], several small molecule S1P receptor modulators have been approved...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
